ID   NCOA3_RAT               Reviewed;        1082 AA.
AC   Q9EPU2;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-OCT-2024, entry version 150.
DE   RecName: Full=Nuclear receptor coactivator 3;
DE            Short=NCoA-3;
DE            EC=2.3.1.48;
DE   AltName: Full=Amplified in breast cancer-1 protein homolog;
DE            Short=AIB-1;
DE   Flags: Fragment;
GN   Name=Ncoa3; Synonyms=Aib1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10906038; DOI=10.1095/biolreprod63.2.361;
RA   Nephew K.P., Ray S., Hlaing M., Ahluwalia A., Wu S.D., Long X., Hyder S.M.,
RA   Bigsby R.M.;
RT   "Expression of estrogen receptor coactivators in the rat uterus.";
RL   Biol. Reprod. 63:361-367(2000).
CC   -!- FUNCTION: Nuclear receptor coactivator that directly binds nuclear
CC       receptors and stimulates the transcriptional activities in a hormone-
CC       dependent fashion. Plays a central role in creating a multisubunit
CC       coactivator complex, probably via remodeling of chromatin. Involved in
CC       the coactivation of different nuclear receptors, such as for steroids
CC       (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin
CC       D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase
CC       activity. Also involved in the coactivation of the NF-kappa-B pathway
CC       via its interaction with the NFKB1 subunit (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC   -!- ACTIVITY REGULATION: Coactivator activity on nuclear receptors and NF-
CC       kappa-B pathways is enhanced by various hormones, and the TNF cytokine,
CC       respectively. TNF stimulation probably enhances phosphorylation, which
CC       in turn activates coactivator function. In contrast, acetylation by
CC       CREBBP apparently suppresses coactivation of target genes by disrupting
CC       its association with nuclear receptors (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Present in a complex containing NCOA2, IKKA, IKKB, IKBKG and
CC       the histone acetyltransferase protein CREBBP (By similarity). Found in
CC       a complex containing NCOA3, AR and MAK (By similarity). Interacts with
CC       ATAD2; the interaction is enhanced by estradiol (By similarity).
CC       Interacts with CARM1 (By similarity). Interacts with CASP8AP2 (By
CC       similarity). Interacts with CSNK1D (By similarity). Interacts with DDX5
CC       (By similarity). Interacts with ESR (By similarity). Interacts with
CC       ESRRB; mediates the interaction between ESRRB and RNA polymerase II
CC       complexes and allows NCOA3 corecruitment to ESRRB, KLF4, NANOG, and
CC       SOX2 enhancer regions to trigger ESRRB-dependent gene activation
CC       involved in self-renewal and pluripotency (By similarity). Interacts
CC       with NFKB1 (By similarity). Interacts with NPAS2 (By similarity).
CC       Interacts with NR3C1 (By similarity). Interacts with NR4A1/Nur77 (By
CC       similarity). Interacts with NR4A3 (By similarity). Interacts with PCAF
CC       (By similarity). Interacts with PPARA (By similarity). Interacts with
CC       PSMB9 (By similarity). Interacts with RARA (By similarity). Interacts
CC       with RXRA (By similarity). Interacts with THRA (By similarity).
CC       Interacts with VDR (By similarity). {ECO:0000250|UniProtKB:O09000,
CC       ECO:0000250|UniProtKB:Q9Y6Q9}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Mainly cytoplasmic and weakly nuclear. Upon TNF activation and
CC       subsequent phosphorylation, it translocates from the cytoplasm to the
CC       nucleus (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed constitutively in uterus.
CC       {ECO:0000269|PubMed:10906038}.
CC   -!- DOMAIN: Contains three Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Motifs 1 and
CC       2 are essential for the association with nuclear receptors, and
CC       constitute the RID domain (Receptor-interacting domain) (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Acetylated by CREBBP. Acetylation occurs in the RID domain, and
CC       disrupts the interaction with nuclear receptors and regulates its
CC       function (By similarity). {ECO:0000250}.
CC   -!- PTM: Methylated by CARM1. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by IKK complex. Regulated its function (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SRC/p160 nuclear receptor coactivator
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF322224; AAG42837.1; -; mRNA.
DR   STRING; 10116.ENSRNOP00000007768; -.
DR   iPTMnet; Q9EPU2; -.
DR   PhosphoSitePlus; Q9EPU2; -.
DR   PaxDb; 10116-ENSRNOP00000059144; -.
DR   UCSC; RGD:620109; rat.
DR   AGR; RGD:620109; -.
DR   RGD; 620109; Ncoa3.
DR   eggNOG; KOG3561; Eukaryota.
DR   InParanoid; Q9EPU2; -.
DR   PhylomeDB; Q9EPU2; -.
DR   Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0004402; F:histone acetyltransferase activity; ISO:RGD.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; IPI:RGD.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IPI:RGD.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:RGD.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; IDA:RGD.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IMP:RGD.
DR   GO; GO:0000993; F:RNA polymerase II complex binding; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0043697; P:cell dedifferentiation; ISS:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; ISO:RGD.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IBA:GO_Central.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0060713; P:labyrinthine layer morphogenesis; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0060744; P:mammary gland branching involved in thelarche; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IDA:RGD.
DR   GO; GO:0033145; P:positive regulation of intracellular steroid hormone receptor signaling pathway; IMP:RGD.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISO:RGD.
DR   GO; GO:1902459; P:positive regulation of stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:2000035; P:regulation of stem cell division; ISS:UniProtKB.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; ISO:RGD.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; ISO:RGD.
DR   Gene3D; 6.10.140.410; -; 1.
DR   Gene3D; 3.30.450.20; PAS domain; 1.
DR   InterPro; IPR010011; NCO_DUF1518.
DR   InterPro; IPR032565; NCOA2/3_DUF4927.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014920; Nuc_rcpt_coact_Ncoa-typ.
DR   InterPro; IPR037077; Nuc_rcpt_coact_Ncoa_int_sf.
DR   InterPro; IPR017426; Nuclear_rcpt_coactivator.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR014935; SRC/p160_LXXLL.
DR   PANTHER; PTHR10684; NUCLEAR RECEPTOR COACTIVATOR; 1.
DR   PANTHER; PTHR10684:SF3; NUCLEAR RECEPTOR COACTIVATOR 3; 1.
DR   Pfam; PF07469; DUF1518; 1.
DR   Pfam; PF16279; DUF4927; 1.
DR   Pfam; PF16665; NCOA_u2; 1.
DR   Pfam; PF08815; Nuc_rec_co-act; 1.
DR   Pfam; PF14598; PAS_11; 1.
DR   Pfam; PF08832; SRC-1; 1.
DR   SMART; SM01151; DUF1518; 1.
DR   SUPFAM; SSF69125; Nuclear receptor coactivator interlocking domain; 1.
DR   SUPFAM; SSF55785; PYP-like sensor domain (PAS domain); 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Acyltransferase; Cytoplasm; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN           <1..1082
FT                   /note="Nuclear receptor coactivator 3"
FT                   /id="PRO_0000094408"
FT   REGION          79..104
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          138..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          236..379
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          399..430
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          447..487
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          503..547
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          581..663
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          686..739
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          712..782
FT                   /note="Interaction with CREBBP"
FT                   /evidence="ECO:0000250"
FT   REGION          786..962
FT                   /note="Acetyltransferase"
FT   REGION          933..1004
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1016..1039
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1059..1082
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           385..389
FT                   /note="LXXLL motif 1"
FT   MOTIF           437..441
FT                   /note="LXXLL motif 2"
FT   MOTIF           723..727
FT                   /note="LXXLL motif 3"
FT   COMPBIAS        138..193
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        203..219
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        236..272
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..377
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        405..430
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        460..479
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        504..520
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        528..544
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        593..617
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        989..1004
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O09000"
FT   MOD_RES         316
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         320
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         387
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         551
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O09000"
FT   MOD_RES         722
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         860
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         866
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         877
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   MOD_RES         988
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y6Q9"
FT   NON_TER         1
SQ   SEQUENCE   1082 AA;  115134 MW;  BA35D946CBC8C080 CRC64;
     IIRRCIQRFF SLNDGQSWSQ KRHYQEAYIH GHAETPVYRF SLADGTIVSA QTKSKLFRNP
     VTNDRHGFVS THFLQREQNG CRPNPILQDK GIRPPAAGCG MSLSPSQSVQ MLGSRTYGVA
     DPSNTGQMAG ARYGASSSVA SLTPGQSLQS PSSYQSNSYG LNMSSPPHGS PGLGPNQQNI
     MISPRNRGSP KMASHQFSPA AGVHSPMGSS GNTGSHSFSS SSLSALQAIS EGVGTSLLST
     LSSPGPKLDN SPNMNINQPS KASSQDSKSP LGLYCEQNPV ESSVCPSNSR DPPVTKENKE
     NSGEASETPR GPLESKGHKK LLQLLTCSSD DRGHSSLTNS PLDSNCKDSS ISVTSPSGVS
     SSTSGAVSST SNMHGSLLQE KHRILHKLLQ NGNSPAEVAK ITAEATGKDT SSTASGGEGS
     VXQEQLSPXK KENNALLRYL LDRDDPSDVL AKELQPQADG GDSKLSQCSC XTNPSSGQEK
     DPKIKTEEVS GDLDNLDAIL GDLTSSDFYN SPTNGSHPGA KQQMFAGPSS LGLRSPQPVQ
     SVRPPYNRAL SLDSPVSVGS VPPVKNVSAF PVLPKQPILA GNPRMMDSQE NYGANMGGPN
     RNVPVNPTSS SGDWGLANSR ASRMEPLASS PLGRAGGDYS AALPRPALGS SGPTLPLRSN
     RLPGARPTLM LQMRAGEVPM GMGVSPYSPA VPSNQPGSWP EGMLSMEQGP HGAQNRPLLR
     NSLDELLGPP SNPEGQSDER ALLDQLHTLL SNTDATGLEE IDRALGIPEL VSQGQALESK
     QDVFQGQEAA VMMDQKAALY GQTYPAQGPP LQGGFHLQGQ SPSLNSMMSQ ISQQGSFPLQ
     GLHPRASMVR PRTNTPKQLR MQLQQRLQGQ QFLNQSRQAL EMKMESPTGA AVMRPMLQSQ
     QAFFNAQMAA QQKRELMNHH LQQQRMAMMM SQPQPQAFSP PPNVTASPSM DGVLAGSAMP
     QAPPQQFPYA TNYGMGQPPE PAFGRGSSPP SAMMSSRMGP SQNAMVQHPQ TAPMYQSSEM
     KGWPSGNLAR NGSFPQQQFA PQANPAAYNM VHMNSSGSHL GQMTMTPMPM SGMPMGPDQK
     YC
//
